141 related articles for article (PubMed ID: 11025699)
21. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
Hashimura T; Okumura K; Akao T; Nakagawa T
Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
[TBL] [Abstract][Full Text] [Related]
22. Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium.
Ecke TD; Gerullis H; Bartel P; Koch S; Ruttloff J
Minerva Urol Nefrol; 2009 Sep; 61(3):249-56. PubMed ID: 19773726
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies.
Tu SM; Hossan E; Amato R; Kilbourn R; Logothetis CJ
J Urol; 1995 Nov; 154(5):1719-22. PubMed ID: 7563331
[TBL] [Abstract][Full Text] [Related]
24. Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: its efficacy and safety in patients even with pretreatment renal insufficiency.
Yang MH; Yen CC; Chang YH; Hsieh RK; Liu JH; Chiou TJ; Fan FS; Lin AT; Huang WJ; Wang WS; Chen KK; Chen PM
Jpn J Clin Oncol; 2000 Dec; 30(12):547-52. PubMed ID: 11210164
[TBL] [Abstract][Full Text] [Related]
25. [M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
Noguchi S; Kubota Y; Shuin T; Masuda M; Misaki H; Yao M; Kondoh K; Sakuramoto T; Hosaka M
Hinyokika Kiyo; 1994 Aug; 40(8):677-82. PubMed ID: 7942364
[TBL] [Abstract][Full Text] [Related]
26. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
Kawai T; Washizuka M; Kihara K; Takahashi T; Sakata Y; Tai K; Nagayama T; Okada K; Kusuyama H; Ishii Y
Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):40-6. PubMed ID: 3611890
[No Abstract] [Full Text] [Related]
27. Neo-adjuvant treatment of infiltrating transitional-cell carcinoma of the bladder with paclitaxel and cisplatin: a phase II trial.
Sousa-Escandon A; Vazquez S; Quintero-Aldana G; Picallo JA; Neira J; Garcia-Novio F; Mateo A; Rico M; Mel JR
Int J Urol; 2002 Mar; 9(3):162-6. PubMed ID: 12010328
[TBL] [Abstract][Full Text] [Related]
28. [Early clinical result of modified M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of renal pelvis and ureter].
Shishido S; Hayakawa M; Higa I; Koyama Y; Hatano T; Osawa A
Hinyokika Kiyo; 1990 Apr; 36(4):401-5. PubMed ID: 2378303
[TBL] [Abstract][Full Text] [Related]
29. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
[TBL] [Abstract][Full Text] [Related]
30. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel in the treatment of advanced urothelial cancer.
Bajorin DF
Oncology (Williston Park); 2000 Jan; 14(1):43-52, 57; discussion 58, 61-2. PubMed ID: 10680149
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer.
Necchi A; Mariani L; Giannatempo P; Raggi D; Farè E; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Pizzocaro G; De Braud FG; Gianni AM; Salvioni R
Clin Genitourin Cancer; 2014 Jun; 12(3):203-209.e1. PubMed ID: 24394493
[TBL] [Abstract][Full Text] [Related]
34. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
35. A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer.
Winquist E; Moore MJ; Chi KN; Ernst DS; Hirte H; North S; Powers J; Walsh W; Boucher T; Patton R; Seymour L
Urol Oncol; 2005; 23(3):143-9. PubMed ID: 15907712
[TBL] [Abstract][Full Text] [Related]
36. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
37. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
[TBL] [Abstract][Full Text] [Related]
38. A nonplatinum combination in metastatic transitional cell carcinoma.
Srinivas S; Guardino AE
Am J Clin Oncol; 2005 Apr; 28(2):114-8. PubMed ID: 15803002
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter.
Papamichael D; Gallagher CJ; Oliver RT; Johnson PW; Waxman J
Br J Cancer; 1997; 75(4):606-7. PubMed ID: 9052419
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel and carboplatin in bladder cancer: recent developments.
Vaughn DJ
Eur J Cancer; 2000 Jul; 36 Suppl 2():7-12. PubMed ID: 10908842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
